Publikationen 
Bücher und Buchkapitel

Publikationen (Auszug)

77.  Plauth  M, Bechmann L, Grajecki D, Gundling F, Kramer L, Kremer AE, Rau M, Schneider A,  Tacke F, van Thiel I. L S2k-Leitlinie Klinische Ernährung in der Hepatologie herausgegeben von der Deutschen Gesellschaft für Ernährungsmedizin (DGEM). Aktuel Ernahrungsmed 2024; 49:256 – 317.  DOI 10.1055/a-2338-1144 

76. Jochmann J, Fink A, Stella A, Feldmann R, Kramer L, Posch C. Prevention of severe immune-related colitis caused by combined immune checkpoint inhibition using vedolizumab: A case report. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e923-e925. doi: 10.1111/jdv.19028. Epub 2023 Mar 23.

75. Pfisterer N, Riedl F, Pachofszky T, Gschwantler M, König K, Schuster B, Mandorfer M, Gessl I, Illiasch C, Fuchs EM, Unger L, Dolak W, Maieron A, Kramer L, Madl C, Trauner M, Reiberger T.

Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study. Liver Int. 2019 Feb;39(2):290-298. doi: 10.1111/liv.13971. Epub 2018 Oct 17.

74. Fabian E, Kramer L, Siebert F, Högenauer C, Raggam RB, Wenzl H, Krejs GJ. D-lactic acidosis - case report and review of the literature. Z Gastroenterol. 2017;55:75-82.

73. Bergthaler, C., Kramer, L. , Steiner, A. and Sator, P. Cholangiosepsis caused by neutrophilic Cholangitis in Plaque Psoriasis. J Cosmet Dermatological Sciences and Applications, 6, 81-84. doi: 10.4236/jcdsa.2016.62010. 

72. Altorjay Á, Szabó É, Boda Z, Kramer L, Ngo LY, Engl W, Firth CL, Ahlstrom ER, Gelmont DM, Pabinger I. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal. Thromb Res. 2015 Mar;135:485-91. doi: 10.1016/j.thromres.2014.12.026. Epub 2015 Jan 2.

71. Dolak W, Schreiber F, Schwaighofer H, Gschwantler M, Plieschnegger W, Ziachehabi A, Mayer A, Kramer L, Kopecky A, Schrutka-Kölbl C, Wolkersdörfer G, Madl C, Berr F, Trauner M, Püspök A; Austrian Biliary RFA Study Group. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc 2014;28:854-60

70.Drolz A, Jäger B, Wewalka M, Saxa R, Horvatits T, Roedl K, Perkmann T, Zauner C, Kramer L, Ferenci P, Fuhrmann V. Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med 2013;39:1227-37.

69. Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B, Reiberger T, Stauber R, Steininger R, Trauner M, Thurnher S, Ulbrich G, Vogel W, Zoller H, Graziadei I; Austrian Society of Gastroenterology and Hepatology.

Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013 Apr;125:200-19

68. Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2013;62:1634-41.

67. Kramer L, Kodras K. Detoxification as a treatment goal in hepatic failure.

Liver Int 2011;31, S3:1-4. 

66. Pirker A, Kramer L, Voller B, Loader B, Auff E, Prayer D. Type of edema in posterior reversible

encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28

patients. AJNR Am J Neuroradiol 2011;32:527-31. (IF= 3.296)

65. Stefaniak J, Baron DM, Metnitz PG, Kramer L. Gastrointestinale Motilitätsstörungen auf der Intensivstation – Ursachen, Konsequenzen und Therapie. Anästhesiol Intensivmed Notfallmed Schmerzther 2010;45:696-706

64. Simanek R, Wuensch M, Edlinger R, Hammerl-Ferrari B, Kramer L, Geissler K.

Komorbiditätsorientierte Onkologie – ein Überblick. Wien Klin Wochenschr. 2010 Apr;122(7-

8):203-18. Review. German. Wien Klin Wschr 2009; (IF=0.995)

63. Kitzberger R, Funk GC, Holzinger U, Miehsler W, Kramer L, Kaider A, Ferenci P, Madl C.

Severity of organ failure is an independent predictor of intracranial hypertension in acute

liver failure. Clin Gastroenterol Hepatol. 2009;7:1000-6. (IF=5.642)

62. Lindner G, Schwarz C, Kneidinger N, Kramer L, Oberbauer R, Druml W. Can we really predict

the change in serum sodium levels? An analysis of currently proposed formulae in

hypernatraemic patients. Nephrol Dial Transplant. 2008;23:3501-8. (IF=3.306)

61. Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, Kramer L, Druml W.

Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis.

2007;50:952-7. (IF= 5.152)

60. Ferenci P, Kramer L. MARS and the failing liver-Any help from the outer space? (Editorial).

Hepatology. 2007;46:1682-4. (IF=10.840)

59. Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG; Austrian Epidemiologic Study on

Intensive Care, ASDI Study Group. Incidence and prognosis of early hepatic dysfunction in

critically ill patients--a prospective multicenter study. Crit Care Med. 2007 Apr;35(4):1099-

104. (IF=6.373)

58. Schöniger-Hekele M, Müller C, Kramer L, Dauber E, Mayr WR, Wrba F, Rockenschaub S,

Mühlbacher F. Graft versus host disease after orthotopic liver transplantation documented

by analysis of short tandem repeat polymorphisms. Digestion. 2006;74(3-4):169-73.

(IF=1.770)

57. Kramer L, Hofer H, Bauer E, Funk G, Formann E, Steindl-Munda P, Ferenci P. Relative impact

of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in

chronic hepatitis C infection. AIDS. 2005 Oct;19 Suppl 3:S85-92. (IF= 4.909)

56. Apfalter P, Stoiser B, Barousch W, Nehr M, Kramer L, Burgmann H. Community-acquired

bacteria frequently detected by means of quantitative polymerase chain reaction in

nosocomial early-onset ventilator-associated pneumonia. Crit Care Med. 2005

Jul;33(7):1492-8. (IF=6.373)

55. Weidekamm C, Cejna M, Kramer L, Peck-Radosavljevic M, Bader TR. Effects of TIPS on liver

perfusion measured by dynamic CT. AJR Am J Roentgenol. 2005 Feb;184(2):505-10. (IF=

2.951)

54. Fuhrmann V, Kramer L, Bauer E, Laferl H, Tucek G, Dekan G, Schenk P. Severe interstitial

pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis

C infection. Dig Dis Sci. 2004 Nov-Dec;49(11-12):1966-70. (IF=1.838)

53. Zimpfer D, Czerny M, Vogt F, Schuch P, Kramer L, Wolner E, Grimm M. Neurocognitive deficit

following coronary artery bypass grafting: a prospective study of surgical patients and

nonsurgical controls. Ann Thorac Surg. 2004 Aug;78(2):513-8; discussion 518-9. (IF= 3.644)

52. Kramer L, Druml W. Ascites and intraabdominal infection. Curr Opin Crit Care. 2004;10:146-

51. (IF=2.665)

51. Kramer L, Bauer E, Jansen M, Reiter D, Derfler K, Schaffer A. Mercury exposure in protein A

immunoadsorption. Nephrol Dial Transplant. 2004;19:451-6. (IF=3.306)

50. Kramer L. Acute liver failure. Wien Klin Wochenschr. 2004;116:67-81. (IF=0.995)

49. Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R. Successful treatment of

refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new

high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr.

2003;115:599-603. (IF=0.995)

48. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A. Citrate

pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care

Med. 2003;31:2450-5. (IF=6.373)

47. Bauer E, Funk GC, Gendo A, Kramer L, Zauner C, Sterz F, Schneider B, Madl C.

Electrophysiological assessment of the afferent sensory pathway in cardiac arrest survivors.

Eur J Clin Invest. 2003;33:283-7. (IF=2.643)

46. Grimm M, Zimpfer D, Czerny M, Kilo J, Kasimir MT, Kramer L, Krokovay A, Wolner E.

Neurocognitive deficit following mitral valve surgery. Eur J Cardiothorac Surg. 2003;23:265-

71. (IF= 2.397)

45. Bauer E, Gendo A, Madl C, Garo F, Roth E, Kramer L. Effects of sorbent suspension dialysis on

plasma amino acid levels in cirrhotic patients with refractory hepatic encephalopathy. Int J

Artif Organs. 2002;25:923-8. (IF=0.931)

44. Kramer L, Bauer E, Gendo A, Madl C, Gangl A. Influence of hydroxy ethyl starch infusion on

serum bilirubin levels in cirrhotic patients treated with artificial liver support. Int J Artif

Organs. 2002;25:918-22. (IF=0.931)

43 Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A,

Ferenci P. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol.

2002;37:349-54. (IF= 7.818)

42. Kramer L, Hörl WH. Hepatorenal syndrome. Semin Nephrol 2002;22:290-301 (IF=4,730).

41 Kramer L, Bauer E. Extracorporeal treatment in fulminant hepatic failure. Pathophysiologic

considerations. Int J Artif Organs 2002;25:929-34 (IF=0.931)

40. Schenk P, Madl C, Kramer L, Zauner C, Funk G, Lang I,Stiebellehner L, Petkov V, Vonbank K,

Ziesche R, Kneussl M, Ratheiser K. Acute vasodilator testing in primary and secondary

pulmonary hypertension. Wien Klin Wochenschr 2001;113:496-503 (IF=0,588)

39. Gendo A, Kramer L, Hafner M, Funk GC, Zauner C, Sterz F, Holzer M, Bauer E, Madl C. Time dependency of sensory evoked potentials in comatose cardiac arrest survivors. Intensive

Care Med 2001;27(8):1305-11. (IF:2.304)

38. Kramer L, Bauer E, Gendo A, Funk G, Madl C, Pidlich J, Gangl A. Neurophysiologic evidence of

cognitive impairment in patients without hepatic encephalopathy after transjugular

intrahepatic portosystemic shunt. Am J Gastroenterol 2001, in press (IF: 2.945)

37. Kramer L, Gendo A, Madl C, Mullen KD, Kaminski-Russ K, Sunder-Plassmann G, Schaffer A,

Zauner C, Roth E, Ferenci P. A randomized, controlled study of sorbent suspension dialysis in

cirrhotic patients with hepatic encephalopathy. Int. J Artif Organs, 2001;24:434-442 (IF:

0.840)

36. Novacek G, Geppert A, Kramer L, Wrba F, Herbst F, Schima W, Gangl A, Pötzi R. Liver

penetration by a duodenal ulcer in a young woman. J Clin Gastroenterol 2001 Jul;33(1):56-60

(IF: 0.763)

35. Schenk P, Petkov V, Madl C, Kramer L, Kneussl M, Ziesche R, Lang I. Aerosolized iloprost

therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe

pulmonary hypertension. Chest 2001;119:296-300 (IF: 2.246)

34. Kramer L, Gendo A, Madl C, Ferrara I, Funk G, Schenk P, Sunder-Plassmann G, Hörl WH.

Biocompatibility of a Cuprophane-Charcoal Based Detoxification Device in Cirrhotic Patients

with Hepatic Encephalopathy. Am J Kidney Dis 2000;36:1193-1200 (IF: 3.084)

33. Grimm M, Czerny M, Baumer H, Kilo J, Madl C, Kramer L, Rajek A, Wolner E. Normothermic

cardiopulmonary bypass is beneficial for cognitive brain function after coronary artery bypass

grafting - a prospective randomized trial. Eur J Cardiothorac Surg 2000;18:270-275 (IF: 0.759)

32. Zauner C, Schneeweiss B, Schneider B, Madl C, Klos H, Kranz A, Ratheiser K, Kramer L, Lenz K.

Short-term prognosis in critically ill patients with liver cirrhosis: an evaluation of a new

scoring system. Eur J Gastroenterol Hepatol 2000;12:517-22 (IF:1.453)

31. Zauner C, Schneeweiss B, Kranz A, Madl C, Ratheiser K, Kramer L, Roth E, Schneider B, Lenz K.

Resting energy expenditure in short-term starvation is increased as a result of an increase in

serum norepinephrine. Am J Clin Nutr. 2000;71:1511-1515 (IF:3.980).

30. Zauner C, Gendo A, Kramer L, Kranz A, Grimm G, Madl C. Metabolic encephalopathy in

critically ill patients suffering from septic or non-septic multiple organ failure. Crit Care Med

2000,28:1310-1315 (IF: 4.260)

29. Madl C, Kramer L, Domanovits H, Woolard RH, Gervais H, Gendo A, Eisenhuber E, Grimm G,

Sterz F. Improved outcome prediction in unconscious cardiac arrest survivors with sensory

evoked potentials as compared to clinical assessment. Crit Care Med 2000, 28:721-6. (IF:

4.260)

28. Kramer L, Tribl B, Gendo A, Zauner C, Schneider B, Ferenci P, Madl C. Partial pressure of

ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000;31:30-34 (IF: 5.849)

27. Zauner C, Schneeweiss B, Kranz A, Klos H, Gendo A, Ratheiser K, Lenz K, Kramer L, Madl C.

Heavy chronic alcohol abuse has no additional adverse effect on the function of extrahepatic

organs and ICU mortality in patients with liver cirrhosis. Wien Klin Wochenschr

1999;111:810-4 (IF: 0.411)

26. Schenk P, Madl C, Kramer L, Ratheiser K, Kranz A, Zauner C, Stain C, Birsan T, Klepetko W,

Müller C. Pneumatosis intestinalis with Clostridium difficile colitis as a cause of acute

abdomen after lung transplantation. Dig Dis Sci. 1998;43:2455-2458 (IF: 1.908)

25. Madl C, Gendo A, Kramer L, Zauner C. Predictive ability of sensory evoked potentials in

comatose patients following cardiopulmonary resuscitation. Acta Anaesth Scand 1998; Suppl

42(112): 111-112. (IF: 0,912)

24. Kramer L. Indikationen und Komplikationen der Plasmapherese im Rahmen der

Intensivmedizin. Intensivmedizin und Notfallmedizin 1998;35:349-55

23. Kramer L, Fasching P, Madl C, Schneider B, Damjancic P, Waldhäusl W, Irsigler K, Grimm G.

Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain

dysfunction in IDDM on intensive insulin treatment. Diabetes 1998, 47:1909-14 (IF: 7.616)

22. Eisenhuber E, Madl C, Kramer L, Steininger R, Yeganehfar W, Ratheiser K, Gangl A.

prognostische Faktoren bei akutem Leberversagen. Wien Klin Wochenschrift 1998;

110/16:564-596 (IF: 0.285)

21. Lenz K, Kranz A, Kramer L, Buder R, Schollmayer E. Effects of Prostaglandin E1 on

extravascular lung water in patients with severe heart failure. Am J Ther 4:389-93,1997

20. Gruy-Kapral C, Base W, Kramer L, Schimetta W, Lenz K. Darmspüllösung zur orthograden

Darmspülung. Wien Klin Wochenschrift 1997;109/5:165-169 (IF: 0.215)

19. Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson’s

disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997;27:358-62 (IF:

3.325)

18. Eisenhuber E, Madl C, Kramer L, Ratheiser K, Grimm G. Detection of subclinical brain

dysfunction by sensory evoked potentials in patients with severe diabetic ketoacidosis.

Intensive Care Med 1997;23:587-589 (IF:1.822)

17. Zauner Ch, Grimm G, Kramer L, Kranz A, Madl C, Ratheiser K, Stockenhuber F, Schneeweiss B,

Lenz K. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: A

comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med

1996;22:559-63 (IF: 1.822)

16. Lenz K, Kranz A, Kramer L, Buder R, Schollmeyer E. Wirkung von Prostaglandin E1 auf das

extravaskuläre Lungenwasser bei Patienten mit schwerer Herzinsuffizienz. Wien Klin

Wochenschrift 1996;108/16:505-509 (IF: 0.215)

15. Grimm M, Grimm G, Yeganehfar W, Madl C, Kramer L, Zuckerman A, Wolner E, Laufer G.

Cyclosporine may affect improvement of cognitive brain function following cardiac

transplantation. Circulation 1996;15;94:1339-1345 (IF: 8.822)

14. Madl C, Kramer L, Yeganehfar W, Eisenhuber E, Kranz A, Ratheiser K, Zauner C, Schneider B,

Grimm G. Detection of nontraumatic comatose patients with no benefit of intensive care

treatment by recording of sensory evoked potentials. Arch Neurol 1996;53:512-6 (IF: 4.260)

13. Henk CB, Kramer L, Schoder M, Bankier AA, Ratheiser K, Mostbeck GH. Weil's disease:

Importance of imaging findings for early diagnosis. Journal of Computer Assisted

Tomography 1996;20:609-12 (IF: 1.402)

12. Kramer L, Madl C, Stockenhuber F, Yeganehfar W, Eisenhuber E, Derfler K, Lenz K, Schneider

B, Grimm G. Beneficial effect of renal transplantation on cognitive brain function. Kidney

International 1996;49:833-8. (IF: 3.995)

11. Eisenhuber E, Zauner C, Madl C, Kramer L, Ratheiser K. Akute Rhabdomyolyse im Status

asthmaticus. Wien Klin Wochenschrift 1996;108/16:521-524 (IF: 0.215)

10. Tschugguel W, Blaicher A, Kramer L, Felfernig M, Jüngling G, Kurz M, Gnant M, Zimpfer M.

Platelet disorders in uremia before and after hemodialysis under influence of low-dose

aspirin. Thrombosis Research 1995;80:225-233 (IF: 1.420)

9. Kramer L, Madl C, Hödl W, Zauner C, Laufer G, Lenz K: Neurologische Komplikationen nach

Herztransplantation. In: Intensivmedizinisches Seminar, Band 8; Seite 65 - 74. Springer

Verlag, Wien - New York, 1995.

8. Zauner CA, Kranz A, Apsner RC, Kramer L, Madl C, Ratheiser K, Stockenhuber F, Schneeweiß

B, Lenz K. Spezielle Probleme bei der Entwöhnung vom Respirator. In: Kleinberger G, Lenz K,

Ritz R, Schneeweiß B, Schuster HP, Waldhäusl W (Hrsg.). Metabolismus - Stoffwechsel und

Ernährung kritisch kranker Patienten. Wien, New York: Springer 1994;127-135.

7. Stockenhuber F, Kranz A, Zauner C, Apsner R, Kramer L, Madl C, Ratheiser K, Schneeweiß B,

Lenz K. Einfluß der Zytokine auf den Stoffwechsel. In: Kleinberger G, Lenz K, Ritz R,

Schneeweiß B, Schuster HP, Waldhäusl W (Hrsg.). Metabolismus - Stoffwechsel und

Ernährung kritisch kranker Patienten. Wien, New York: Springer 1994;61-72.

6. Stockenhuber F, Kranz A, Zauner C, Apsner R, Kramer L, Madl C, Ratheiser K, Schneeweiss B,

Lenz K. Einfluß der Zytokine auf den Stoffwechsel. In: K. Lenz, A.N. Laggner (Hrsg):

Intensivmedizinisches Seminar Band 7, 1994, pp 127-35

5. Madl C, Grimm G, Kramer L, Yeganehfar W, Koppensteiner R, Hirschl M, Hirschl MM,

Ugurluoglu A, Ehringer H. Cognitve brain function in non- demented patients with low- grade

and high- grade carotid artery stenosis. Eur J Clin Invest 1994; 24: 559-564 (IF: 2.349)

4. Madl C, Grimm G, Ferenci P, Kramer L, Yeganehfar W, Lenz K. Serial recording of sensory

evoked potentials - a noninvasive prognostic indicator in fulminant hepatic failure.

Hepatology 1994;20:1487-1494 (IF: 5.569)

3. Schneeweiss B, Pammer J, Ratheiser K, Schneider B, Madl C, Kramer L, Kranz A, Druml W,

Graninger W, Lenz K, Ferenci P, Gangl A. Energy metabolism in fulminant hepatic failure.

Gastroenterology 1993;105:1515-21 (IF: 5.919)

2. Madl C, Koppensteiner R, Wendelin B, Kramer L, Kranz A, Grimm G, Schneeweiss B, Lenz K,

Ehringer H. Effect of immunoglobulin administration on blood rheology in patients with

septic shock. Circulatory Shock 1993;40:264-7. (IF: 2.182)

1. Madl C, Grimm G, Kramer L, Yeganehfar W, Sterz F, Schneider B, Kranz A, Schneeweiss B,

Lenz K. Early prediction of individual outcome following cardiopulmonary resuscitation.

Lancet 1993;341:855-58 (IF: 15.940)

​

​